Suchergebnisse - "Antibodies, Monoclonal, Humanized"

PubPharm (56.138)

51

Graves disease in a patient treated with dupilumab for severe asthma

enthalten in: Internal medicine journal | 2024

von Tang, H. | Ho, W. | Wang, S. | +3

52

Serious Bacterial Infections Associated with Eculizumab : A Pharmacovigilance Study

enthalten in: Internal medicine (Tokyo, Japan) | 2024

von Okusa, S. | Takizawa, T. | Imai, S. | +5

53

Intrahepatic Cholangiocarcinoma with High Microsatellite Instability and Tumor Mutation Burden That Responded Significantly to Pembrolizumab but Perforated within a Short Period

enthalten in: Internal medicine (Tokyo, Japan) | 2024

von Yamazaki, S. | Kubota, K. | Shimizu, A. | +9

54

The Real-World Outcome of First Line Atezolizumab in Extensive-Stage Small Cell Lung Cancer : A Multicenter Prospective Cohort Study

enthalten in: Cancer research and treatment | 2024

von Choi, M. | Kim, Y. | Lee, J. | +8

55

Efficacy and safety of rademikibart (CBP-201), a next-generation mAb targeting IL-4Rα, in adults with moderate to severe atopic dermatitis : A phase 2 randomized trial (CBP-201-WW001)

enthalten in: The Journal of allergy and clinical immunology | 2024

von Silverberg, J. | Strober, B. | Feinstein, B. | +13

56

Effectiveness and safety of sarilumab in patients with rheumatoid arthritis : A multicenter, retrospective, inverse probability of treatment-weighted analysis based on the FRAB-registry

enthalten in: Clinical rheumatology | 2024

von Harada, H. | Kondo, M. | Maeyama, A. | +8

ErratumIn: Clin Rheumatol. 2024 Mar 15;:. - PMID 38489137

57

Stool Microbiome Signature Associated with Response to Neoadjuvant Pembrolizumab in Patients with Muscle-invasive Bladder Cancer

enthalten in: European urology | 2024

von Pederzoli, F. | Riba, M. | Venegoni, C. | +16

CommentIn: Nat Rev Urol. 2024 Feb;21(2):63. - PMID 38228740

58

Zimberelimab combined with systemic therapy extended tumor control in post-radiotherapy cervical cancer with brain metastases : A case report

enthalten in: The journal of obstetrics and gynaecology research | 2024

von Ni, B. | Pan, M. | He, L. | +1

59

Multivalent Rhamnose-Modified EGFR-Targeting Nanobody Gains Enhanced Innate Fc Effector Immunity and Overcomes Cetuximab Resistance via Recruitment of Endogenous Antibodies

enthalten in: Advanced science (Weinheim, Baden-Wurttemberg, Germany) | 2024

von Li, Y. | Lin, H. | Hong, H. | +5

60

Bemarituzumab as first-line treatment for locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma : final analysis of the randomized phase 2 FIGHT trial

enthalten in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association | 2024

von Wainberg, Z. | Kang, Y. | Lee, K. | +15